Interventions
Explanation for the choice of comparators {6b}
A goal-oriented primary outcome
To evaluate the effects of a biopsychosocial intervention to prevent and resolve crises in a heterogeneous population, there is a need for a goal-oriented outcome comprising this variability. The goal of the intervention and the outcome will necessarily vary from patient to patient [
26]. We have therefore translated and modified a validated individual goal-oriented interview (The Bangor Goal-Setting Interview, BGSI) [
40] to establish a common primary outcome to be used in the RCT. The PRACTIC Goal Setting Interview (PGSI) is a Norwegian adapted version of the BGSI. In the PGSI, the individual goals set for each patient represent treatment and actions targeting the challenges and symptoms that trigger and maintain the patient’s crisis. The difference in goal achievement between the intervention and control groups, as further explained in the “
Methods” section, defines our primary outcome.
In this trial, the primary outcome is the difference in change between the intervention and control groups in individual goal achievements assessed by the PGSI [
39]. The patients in the control group will receive care and treatment as usual, but they will probably also profit from the extra attention given by the home care services because of their participation in the RCT and because of the use of the measure for the primary outcome, the PGSI. In this way, we can isolate any effects on goal achievements to prevent or resolve crises to the main difference between IMs and CMs, i.e. the TIME intervention.
Intervention description {11a}
Joint education and training for the staff in intervention municipalities (IMs) and control municipalities (CMs)
Depending on the size and organisation of the home care services, approximately four project nurses from each organisational unit of the home care services in each IM and CM will be given special responsibility in the trial. Before randomisation, these nurses will complete a 1-day educational course on the procedures for the trial. Their main task will be to recruit participants according to the inclusion criteria, obtain written consent for participation, and facilitate the interviews for the assessments of the participants at baseline, 3 months, and 6 months. The manager of the home care services will select these nurses in the municipality based on the following criteria: health care professionals who work on a nearly full-time basis, have shown interest in professional development, and have gained legitimacy with the rest of the staff. Thus, these health care professionals can be selected among registered nurses, auxiliary nurses, or members of other professional groups (e.g. social workers or occupational therapists) in home care services.
After this coeducational session for both the IMs and CMs, the CMs will continue care and treatment as usual (CTAU). Care and treatment as usual will usually involve medication follow-up and medical procedures, personal care, dressing, and bathroom assistance.
Specific education and training of staff in the IMs
The staff in the IMs will complete 4 h of lectures, training, and role-play related to TIME. The educational programme is aimed at as many employees as possible in the organisation and provides basic knowledge about the TIME model. The education and training team will consist of eight specialist registered health care professionals in geriatrics or geriatric psychiatry and one physician with special competence in nursing home medicine. All members of the education and training team are familiar with TIME and have used the model for some years in real-world clinical settings. The lectures will be standardised according to the steps listed in the TIME manual.
The leaders of the home care service in the IMs will attend these lectures to ensure that these leaders provide support to the staff during the trial. We will also encourage the GPs in the municipalities to participate. Each staff member in the IMs will be provided with the TIME manual, which describes the intervention step by step. They will also be given access to an educational film about TIME and to a website to support the intervention. The project nurses from the IMs who participated in the joint education and training for the inclusion criteria will now hold a special responsibility for putting the model into practice based on the manual. These nurses will therefore receive three additional hours of education, training, and role-play on the different components of TIME and the implementation of the intervention. In the trial, they will be referred to as TIME administrators. Immediately after randomisation and allocation, the project management team will contact these TIME administrators via telephone and instruct them to begin to implement the intervention according to the TIME manual for the patients included in the trial. This telephone call will be made from a few days up to 1 week before the education and training sessions are given. The TIME manual is available online.
The TIME model is described in detail in the TIME manual, which provides a step-by-step guide for implementing the model [
24]. The different components of TIME acting together thus produce a standardised approach with the goal of preventing and resolving crises for patients receiving home care services. In the assessment phase, the GP will carry out a somatic and mental examination of the patient, and medicine prescriptions will be critically reviewed. The staff will gather the patient’s background information and medical history, assess the level of activities of daily living [
41] and nutritional status (the Malnutrition Screening Tool, MST) [
42], and participate in the goal-setting interview (PGSI). This phase is described in Table
1. The duration of this phase varies from 1 day to 4 weeks, depending on the patient’s situation and symptoms. After the assessment phase, the reflection phase begins. At this stage, a case conference is held for all stakeholders around the patient, i.e. nursing staff, GPs, physiotherapists, and occupational therapists. The aim of the case conferences is to create a mutual understanding of the patient’s situation and to tailor a detailed treatment plan to be tested in the coming weeks. This reflection is carried out systematically using a five-column table on a board or a screen, and the following five aspects are reviewed: considered facts, interpretation, feelings within the staff about the situation, actions to take, and evaluation. The timeframe and agenda for the case conferences are outlined in Table
2. The final phase is the action and evaluation phase. In this phase, each treatment measure in the plan is put into practice and then systematically evaluated. The timeframe for the entire intervention with TIME will vary from 1 or 2 weeks up to 8 weeks depending on the patient’s situation.
Table 1
The assessment phase
The following should be performed: | PRACTIC Goal Setting Interview (PGSI) |
Personal history and conversation with the person: what is the person’s perspective? For example, “Who am I?” |
Medical history: A summary |
Somatic and psychological assessment and examination |
ADL assessment: Activities of daily living Nutritional screening |
Suspected conditions: | ☐Yes ☐No If dementia is suspected, start a basic dementia assessment. In the case of known dementia, assess the degree of dementia |
☐Yes ☐No If pain is suspected, conduct a pain assessment |
☐Yes ☐No In the case of behavioral and psychological symptoms, map the symptoms |
☐Yes ☐No In case of nutritional difficulties, perform nutritional mapping |
☐Yes ☐No In case of acute confusion (delirium), map the synptoms and contact a doctor |
Agree upon a time and place for the case conference: TID administrator/manager |
Table 2
Agenda and timeframe for the case conferences
Activity | Preparation: Convene a meeting and prepare a meeting room with a blackboard or similar facilities (projector, if available). Check that a flip pad and markers are available. As many as possible from the home care service staff should attend the conference. The leading registered nurse and the GP should attend the conference, if possible |
1. Status Report: Personal history and main points from the patient’s medical record are presented, 10 min. Decide in advance who should prepare and present the patient’s personal history and the main points from the medical record |
2. Create a problem list, approximately 5 min |
3. Prioritise problems from the list, approximately 5 min |
4. Draw a five − column table on the whiteboard that includes facts – interpretations (thoughts)—emotions – actions – evaluation |
5. Describe facts from the registration and assessment phase one problem at a time, approximately 10 min |
6. Suggest interpretations – guided discovery – discuss and reflect on the interpretations, approximately 10 min |
7. Describe any emotions experienced by the staff with interpretations by the staff, approximately 10 min |
8. Suggest SMART (Specific, Measurable, Achievable, Relevant, Time-bound) actions based on the interpretations and decide how and when to perform an evaluation of the actions, approximately 10 min |
9. Summarise interpretations and actions and close the meeting, approximately 5 min |
One specialist registered nurse from the education and training team will attend and supervise the TIME administrators’ first case conference on their first patient in their municipality. For the remainder of the intervention and for the other patients included in the trial, the TIME administrators and staff will carry out the intervention independently.
Criteria for discontinuing or modifying allocated interventions {11b}
Participation in the project is voluntary. The participant can withdraw consent at any time and without giving any reason. This will have no consequences for further home care services. We have not established any other criteria for modifying the allocated intervention for any given trial participant.
Members of the research team at the AFS research centre will contact the local project nurses in each municipality twice with 2-month intervals. A structured telephone interview with a checklist that consists of the core components of TIME (i.e. the assessment phase, case conferences, the actions taken and systematic evaluations of these actions) will be carried out.
Relevant concomitant care permitted or prohibited during the trial {11d}
The services and treatment measures provided are generally recognised care and treatment. The patients in the control group will receive care and treatment as usual. We have no other criteria for concomitant care permitted or prohibited during the trial.
Provisions for post-trial care {30}
Not applicable, as there is no post trial care.
Outcomes {12}
Baseline data and primary and secondary outcome measures
The primary outcome of the trial is the difference in the change between the intervention and control groups in individual goal achievement to resolve or alleviate the challenges regarding crises between baseline and 3 months using the PGSI (scale of 1–10) [
40]. We chose this primary outcome because there is a need for a targeted outcome that comprises the variability in a heterogeneous population. It is very unlikely that a participant would be harmed due to participation in the RCT; therefore, it is not deemed necessary to have a harm outcome in the study. In the RCT, no new experimental treatments for the patients will be introduced, and care and all treatment actions will rely on recommended national care and treatment guidelines.
The secondary outcomes are the differences in the change between the intervention and control groups in the PGSI scale at 6 months, in neuropsychiatric symptoms (NPSs) measured by the Neuropsychiatric Inventory (NPI-NH) [
43], quality of life measured by the Quality of Life in Late-Stage Dementia scale (QUALID) [
44,
45], distress perceived by the next of kin measured by the Relative Stress Scale [
46], rejection of care measured by the Minimum Data Set [
47], activities of daily living assessed with the Physical Self-Maintenance Scale (PSMS) [
41], prescribed medications collected from the medical records [
48], frailty measured with the Clinical Frailty Scale (CFS) [
39], institutionalisation at 3 and 6 months, and pain and discomfort assessed by the EQ-5D questionnaire [
49] at 6 months. All these questionnaires have been proven to have acceptable validity and reliability. The trial will also collect data to be used as covariates in the RCT and to describe the sample of participants. These data will be collected with questionnaires answered by the staff in home care services:
a)
Age (covariate in the RCT), sex, level of education and employment status, marital status, living conditions (living alone or with someone)
b)
Hours a week and type of home care service
c)
Relation to next of kin (e.g. next of kin and how often they meet)
d)
Physical health measured with the General Medical Health Rating Scale (GMHR) [
50]
e)
Cognitive function assessed by the Clinical Dementia Rating Scale (CDR) [
51] (covariate in the RCT).
Participant timeline {13}
The study timeline for enrolment, intervention, and assessment is described in Table
3. In addition, description of the questionnaires and the time points at which they are administered is provided in Table
4.
Table 3
Enrolment, intervention, and assessment schedule
Enrolment | | | | | |
Eligibility | X | | | | |
Informed consent | X | | | | |
Allocation/randomisation | | | X | | |
Interventions | | | | | |
Joint education and training | | X | | | |
Intervention group | | | | X | X |
Control group | | | | X | X |
Assessments | | | | | |
Baseline | | X | | | |
3 months | | | | X | |
6 months | | | | | X |
Table 4
Overview of data collection with primary and secondary outcome measures
Characteristics of the participants |
Agea, sex, level of education and employment status, marital status and living conditions | Data assessors from AFSb | Staff members in home care services | X | | |
Hours a week and type of service from the home care service | Data assessors from AFS | Staff members in home care services | X | | |
Number of visits per day from the home care service | Data assessors from AFS | Staff members in home care services | X | | |
Relation to next of kin (e.g. next of kin and how often they meet) | Data assessors from AFS | Staff members in home care services | X | | |
Diseases (known diagnosis) | Data assessors from AFS | Staff members in home care services | X | | |
Frailty measured with the Clinical Frailty Scale (CFS)c | Data assessors from AFS | Staff members in home care services | X | | X |
Physical health measured with the General Medical Health Rating Scale (GMHR)d | Data assessors from AFS | Staff members in home care services | X | | |
Cognitive function measured with the Clinical Dementia Rating Scale (CDR)e | Data assessors from AFS | Staff members in home care services | X | | |
Primary outcome |
PRACTIC Goal Setting Interview (PGSI)f | Data assessors from AFS | Patient, next of kin and staff members in home care services | X | X | X |
Secondary outcomes |
Medication from medical records | Data assessors from AFS | Staff members in home care services | X | X | X |
Rejection of care evaluated by the Minimum Data Set (MDS)g | Data assessors from AFS | Staff members in home care services | X | X | X |
Neuropsychiatric Inventory Nursing Home version (NPI-NH)h | Data assessors from AFS | Staff members in home care services | X | X | X |
Activities of daily living assessed with the Physical Self-Maintenance Scale (PSMS)i | Data assessors from AFS | Staff members in home care services | X | X | X |
The EQ-5D questionnairej to evaluate pain and discomfort | Data assessors from AFS | Patient | X | | X |
Quality of Life in Late-Stage Dementia scale (QUALID)k | Data assessors from AFS | Staff members in home care services | X | X | X |
RSS (Relative Stress Scale)l Next of kin | Data assessors from AFS | Next of kin | X | X | X |
Sample size {14}
Sample size calculation based on the primary outcome
The proposed sample of 150 participants is based on a power calculation with clusters of approximately five participants from each of the 30 municipalities. Based on a previous trial, a minimal clinically important average difference on the PGSI scale between participants in the intervention and control groups was set to 2 points with a standard deviation (SD) for change of 2.83 in each group [
40]. To observe a statistically significant difference with a power of 80%, an intracluster (municipality) correlation coefficient (ICC) of 10%, and an estimated attrition rate of 25% for the primary outcome at 3 months, we will need approximately 150 participants. We assume a high attrition rate since the participants are at high risk for acute institutionalisation (see the inclusion criteria).
Recruitment {15}
The local project nurses (See:
Who will take informed consent? {26a}) will support the research team in the recruitment of participants. Care providers for the intervention will, however, be the permanent staff in the home service units. Each municipality must recruit approximately five patients, and the project nurses have one week to include participants in the study. These nurses will know the patient well and assess whether the inclusion criteria are fulfilled for each patient for participation in the study. The project nurses will ask eligible patients if they wish to participate when they visit the patient in their home. Each IM and CM will be reimbursed 900 EUR for the time spent in this recruitment process.
Assignment of interventions: allocation
Sequence generation {16a}
This trial will be conducted as a cluster randomised controlled study, where each municipality represents a cluster. The clusters will be randomised to either receive the locally adapted TIME intervention (the intervention group) or care and treatment as usual (the control group). The intervention is a biopsychosocial intervention that involves the entire interdisciplinary team and staff in the home care service units of the participating municipalities to optimise the approach towards a group of patients in the municipalities. Thus, without cluster randomisation, the study runs the risk of implementing all or parts of the intervention model among individual control patients in the same municipalities [
52].
The municipalities will be stratified by size into three blocks to ensure approximately the same number of patients in the two trial arms. These blocks are (1) small municipalities, (2) medium-sized municipalities, and (3) large municipalities. The municipalities within each block will be randomly assigned to either the intervention group or the control group. A statistician independent of the project management team and the municipalities will perform a computer-generated randomisation procedure.
Concealment mechanism {16b}
The randomisation results for the municipalities will be sent from the independent statistician by email to a researcher (AV) in the research team by an encrypted file and a connection key. Only this researcher and the research team will know the randomisation results.
Implementation {16c}
A statistician independent of the project management team and the municipalities will perform the randomisation by the use of a computer procedure. The project management team will provide the home care services in the municipalities with the randomisation and allocation results immediately after the randomisation procedure. The intervention will start with the educational sessions (11a) within 1 to 2 weeks after randomisation.
Assignment of interventions: blinding
Who will be blinded {17a}
The baseline assessments, before randomisation, will be performed by the same data assessors by visiting the participants in their homes and interviewing them, the next of kin, and the staff members who know the patient best. The data assessors in the study will be blinded to whether the municipality is allocated to the intervention group or the control group at the assessments at 3 months and 6 months. These data assessments will be performed by telephone by interviewing the staff 3 months and 6 months after baseline. The statistical data analyst will also be blinded to the allocation results. After baseline and the allocation process, the home care services, the training group, and the patients cannot be blinded.
Procedure for unblinding if needed {17b}
Unblinding during the study will not be permitted, and the data assessors will be blinded to the randomisation result.
Data collection and management
Plans for assessment and collection of outcomes {18a}
The data assessors are specially trained nurses from the project’s research centre who are not affiliated with the municipalities. All data assessors are registered nurses with substantial experience and formal training in the use of the assessment scales, and they will attend a 1-day course about the use of the assessment scales before the start of the trial. A description of the questionnaires, including data assessors, respondents, and the time points at which they are administered, is provided in Table
4.
The participants will be assessed at three time points, at baseline and at 3 and 6 months, during the 6-month RCT. The participants in the intervention group will also be followed up by phone by the local project nurses using a checklist for adherence to the study protocol 2 and 4 months from baseline. For all participants who withdraw from the study before the 6-month follow-up, the date and reason for discontinuation will be registered by the local project nurses and reported to the research team.
Data management {19}
The data protection official, Innlandet Hospital Trust, has approved the applications for data entry and security. The collected data from the sampled patients will be deidentified and stored on a secured research server at Innlandet Hospital Trust.
Confidentiality {27}
Specially trained nurses (data assessors) from the project’s research centre who are not affiliated with the municipalities will travel to the municipality to assess baseline data using a paper case report form (CRF). Data will also be assessed by the same data assessors at 3 and 6 months using the CRF, such as telephone interviews with nurses from the municipality. The data assessors will deliver the CRFs directly to the researchers in the project group at the research centre when they have been completed. The data will then be scanned and transferred into SPSS (Statistical Package for the Social Sciences [
53]) at the project’s research centre. The SPSS file will be stored on a secure server at Innlandet Hospital Trust. The data will be kept for 5 years after the end of the project for control reasons.
Plans for collection, laboratory evaluation, and storage of biological specimens for genetic or molecular analysis in this trial/future use {33}
N/A. Collection, laboratory evaluation, and storage of biological samples for genetic or molecular analysis is not applicable in this study.
Statistical methods
Statistical methods for primary and secondary outcomes {20a}
Data processing and statistical analysis of quantitative data
The data will be presented as frequencies and percentages for categorical variables and means with standard deviations for continuous variables. The normality of the continuous variables will be assessed graphically. If necessary, skewed data will be transformed. The analyses for primary and secondary outcomes will be adjusted for baseline PGSI scores, baseline severity of dementia (Clinical Dementia Rating), and age of the participants. Differences in the changes in outcomes between the intervention group and the control group will be assessed by a linear mixed model with fixed effects for time component and group and the interaction between the two. A significant interaction will imply the differences in change between the groups. Random effects for patients nested within municipalities and slopes (if significant) will be included in the model. Individual time point contrasts will be derived within each group at each time point with the corresponding 95% confidence intervals and p-values. The linear mixed model correctly adjusts estimates for intracluster correlations as well as for intraindividual correlations due to repeated measurements over time.
The analyses for primary and secondary outcomes will be adjusted for differences in:
-
Baseline PGSI scores
-
Baseline severity of dementia (Clinical Dementia Rating Scale, CDR) [
51]
-
Age
Other descriptive analysis to further describe the sample of participants:
f)
Sex, level of education, and employment status, marital status, living conditions (living alone or with someone)
g)
Hours a week and type of home care service
h)
Relation to next of kin (e.g. next of kin and how often they meet)
i)
Physical health measured with the General Medical Health Rating Scale (GMHR) [
50]
Interim analyses {21b}
N/A. No preliminary analyses will be performed, and we have not developed any stopping guidelines. All treatment measures developed and implemented for the patients in the intervention group are regular and known clinically accepted procedures and care, with no new experimental measures or treatments.
Methods for additional analyses (e.g. subgroup analyses) {20b}
N/A. There are currently no planned additional analyses.
Methods in analysis to handle protocol non-adherence and any statistical methods to handle missing data {20c}
To handle protocol nonadherence, the analysis will be performed as an intention-to-treat analysis. The linear mixed model handles unbalanced data by allowing the inclusion of all available information, including dropouts and missing data.
Plans to give access to the full protocol, participant-level data, and statistical code {31c}
The last version of the full protocol and the datasets will be made available on the project’s website:
www.practic.no. Participant-level data and the statistical code will only be accessible to the central research team.
Oversight and monitoring
Composition of the coordinating centre and trial steering committee {5d}
This study is a part of the larger PRACTIC study. The project is owned by the Research Centre for Age-Related Functional Decline and Disease (AFS), Innlandet Hospital Trust, Ottestad, Norway. The core research group with the project leader, work package leaders, postdocs, PhD students, and a project coordinator will have day-to-day responsibility for the project. A project group comprising the core research group and other research staff will have regular meetings once a month to discuss the project. The PhD students and research staff will collaborate with participating municipalities in the project and have regular dialogue. The PhD students are responsible for coordinating and collaborating with the training group for educational sessions during the intervention and the data assessor group throughout the RCT.
The project has organised two reference groups, one with end-users (patients and next of kin) and one with staff from home care services, including GPs. The reference groups will meet with the central project group regularly during the project period. The design of the project will enable close cooperation with end-users and stakeholders in the municipalities through the establishment of local project groups in each municipality.
Composition of the data monitoring committee, its role and reporting structure {21a}
This trial does not require periodic inspections of cumulative outcome data. The study involves little risk for the participants, so there is no need for periodic inspection of accumulating outcome data by a formal committee such as a data monitoring committee (DMC).
Adverse event reporting and harms {22}
The data protection official, Innlandet Hospital Trust, has approved applications for the trial. If participants have questions about privacy in the project, they can contact the institution’s data protection officer. If any adverse events occur, this will be reported to the data protection officer.
In this study, no new or experimental treatments will be provided to the participants, and they will receive only traditional health care and assistance for their needs. The intervention mainly comprises an introduction of a more person-centred way of working for the staff that is very unlikely to cause harm to the patients. The principal investigator (PI) for the study is responsible for the daily operation of the study, and the participants or their next of kin can contact the project leader in any cases of harm or questions pertaining the study.
Frequency and plans for auditing trial conduct {23}
N/A. There is no requirement for the frequency of or procedures for auditing the conduct of the trial.
Plans for communicating important protocol amendments to relevant parties (e.g. trial participants, ethical committees) {25}
In the event of important protocol changes, a change notification will be sent to the data protection officer, Innlandet Hospital Trust.
Dissemination plans {31a}
The datasets supporting the conclusions of this article will be available on the website for the PRACTIC study. Three papers will be published in international peer-reviewed open access journals. In addition, the results from this study will be presented orally at national and international congresses. The results of the project will also be communicated to participants in the train the trainer course in TIME.
Discussion
Through interventions customised to the patients and targeting their next of kin, the patients’ social context, and health care services, we hypothesise that crises can be prevented and resolved with the use of an adapted TIME intervention. Home care services can be described as a complex organisation and consist of many different units and functions involved in the services [
7]. There is a need for a holistic understanding. This project aims to test the effectiveness of an adapted version of a biopsychosocial person-centred model (TIME) to prevent and resolve crises for frail residents receiving home care. The strength of the model is that it was developed over a period of several years and has been used in clinical practice for other complex problems, such as nutritional deficiencies, multimorbidity, and general loss of function [
30]. A pilot study demonstrated the feasibility of the model in home care services [
33].
One of the challenges of including patients who receive home care services in trials is that they represent a heterogeneous group and vary substantially in function, age, and living conditions as well as illness and diseases [
8]. Many of these patients have several chronic conditions (multimorbidity) [
4], and most frail individuals are multimorbid [
11]. Based on this, we have chosen the inclusion criteria for the study to be quite broad to make the trial more pragmatic [
54]. The advantage is that the TIME model is used in situations and challenges where the staff deems it necessary to work in a structured way. A literature review of the definition of crises in dementia care noted that patient perceptions, their next of kin, and health care staff are interrelated and depend on the type of crisis stressors and where the crises take place [
15]. This strengthens the model’s properties in a home care context and the need for a holistic approach to the crisis.
The study is a cluster randomised controlled trial (RCT), which is the gold standard for testing the effectiveness of a certain type of treatment or model. Furthermore, we have combined this design with participatory action research (PAR) to allow for local adaptations of the intervention to the local context and needs [
23,
24]. A flexible intervention is an important factor for the measures to be effective and increase their applicability in practice. The study by Lichtwarck et al. [
28] showed that even though TIME is a complex intervention, it did not require major changes in the organisations’ structures or routines, and the implementation costs were estimated to be low. For complex interventions in complex settings, flexibility within certain limits is a success factor. According to Hawe et al. [
24], it is the function and processes of the intervention that should be standardised, not details in the components of the intervention.
Our study design has some limitations. We do not require a specific diagnosis as an inclusion criterion; instead, we will include patients who are frail, defined as a CFS score from 5 to 8, and considered by the home care services to be in an unstable situation, an imminent crisis. This will necessarily result in a heterogeneous sample for the trial and may jeopardise the possibility of demonstrating any effectiveness of the intervention. On the other hand, the sample will mimic a real-world population receiving home care services and add to the pragmatic character of the trial [
54]. Regardless of their diagnosis, the patients are frail and require comprehensive assessments and follow-up from home care services.
Since the participants in the trial represent a heterogeneous group, there is a need for a primary outcome that accounts for this variation between patients. The treatment measures taken during the trial and the outcomes will necessarily vary from patient to patient [
26]. The PGSI has the potential to address this heterogeneity and will guide the development of measures during the intervention. We will therefore be able to measure potential differences in change in goal achievement measured with the PGSI between IMs and CMs 3 months from baseline. The PGSI is a Norwegian adapted version of the BGSI [
40], a validated tool that has been simplified and adapted to be used by home care services. We will shortly after the trial perform a qualitative content validation study of the PGSI. This goal-setting interview is also considered clinically important and can be used by home care services after the intervention has been completed. A limitation may be that introducing the PGSI as the primary outcome in the trial will affect all municipalities, including the control municipalities. The PGSI is a minor intervention in itself and may reduce the possibility of demonstrating a significant difference between IMs and CMs pertaining to the primary outcome. On the other hand, introducing the PGSI in both groups may reduce the risk of observer bias, a bias that will often be present in a trial that is only single-blinded. By introducing the PGSI for the staff in the CMs, they will have a sense of being part of an intervention [
55].
Potential impact of the proposed research
Due to the multimorbidity and diversity of the patients receiving home care services, care interventions can hardly be introduced as standardised solutions based on single diagnoses but should be implemented through holistic approaches embracing multimorbidity and different functional impairments. The PRACTIC study will enhance innovation in the development of new knowledge and the development of a new biopsychosocial approach towards each patient. This process will be adapted to local structural conditions. The project is likely to enforce systematic cooperation between home care services and GPs, where diagnostic work-up and follow-up will be one of the most important tasks. For home care services, this means a cultural change from a mainly task-oriented service based on support for the activities of daily life to an interdisciplinary assessment and follow-up of functional impairment and diseases for these patients. If successful, because of the trial’s pragmatic character, the intervention can easily be implemented in health care services with minimal extra resources. Improving the approaches to crises may also reduce the use of specialist health care services.
Trial status
In accordance with the trial protocol version 9, dated 30 June 2023, the cluster randomised trial started with inclusion of the first patients on the 6 January 2023, and the last patients will be included on the 26 October 2023.
The last visit to the patients is scheduled for April 12, 2024. The reason for the delayed submission is the comprehensive recruitment process that involves both participating municipalities and study participants. An unexpected lack of resources pertaining enough staff in the municipalities to support the recruitment has affected the ability to submit the protocol earlier. Most of the efforts in the research team has been directed towards optimising and supporting this recruitment process. The recruitment was performed through multiple stages during the RCT in 2023. Since the municipalities involved in the project have varying start dates for the RCT, the recruitment of the last patient was on 20 October 2023. The final visit to the patients is scheduled for April 12, 2024.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit
http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (
http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.